Form 4: Larry Robbins of Glenview Capital Sells CVS Health Corp Shares

Larry Robbins, a Director of CVS Health Corp, reports selling shares of the company's common stock held by Glenview Investment Funds between May 2 and May 6, 2025.

Summary

• Larry Robbins, a Director of CVS Health Corp, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates sales of CVS common stock held by Glenview Investment Funds, where Robbins serves as Founder, Portfolio Manager, and CEO of Glenview Capital Management, LLC.
• The sales occurred between May 2, 2025, and May 6, 2025.
• On May 2, 2025, 1,679,736 shares were sold at an average price of $67.3857, 222,556 shares were sold at an average price of $68.3827 and 373,776 shares were sold at an average price of $69.6556.
• On May 5, 2025, 1,226,933 shares were sold at an average price of $67.3669 and 96,999 shares were sold at an average price of $67.9932.
• On May 6, 2025, 150,000 shares were sold at an average price of $66.6714.
• Following these transactions, the number of shares held by Glenview Investment Funds decreased from 10,267,063 to 8,196,799.
• Robbins disclaims beneficial ownership of these shares except to the extent of any pecuniary interest.

Sentiment

Score: 4

Explanation: The document itself is neutral, but the information it contains (insider selling) is generally viewed with mild negativity by the market.

Negatives

• The sale of a significant number of shares by a director and related funds could be perceived negatively by investors.

Risks

• Continued selling pressure from Glenview Investment Funds could negatively impact CVS Health Corp's stock price.
• The market may interpret these sales as a lack of confidence in the company's future prospects.

Management Comments

• The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

Industry Context

Form 4 filings are a routine part of insider trading activity and are closely watched by investors for signals about a company's prospects. Large sales by insiders can sometimes raise concerns, while purchases are often seen as a positive sign.

Comparison to Industry Standards

• Comparing the size and frequency of these sales to those of other directors or major shareholders in CVS Health Corp and similar companies (e.g., UnitedHealth Group, Walgreens Boots Alliance) could provide context on whether these transactions are unusual.
• Analyzing the trading patterns of Glenview Capital in other healthcare companies could also offer insights.

Stakeholder Impact

• Shareholders may react to the news of the share sales, potentially impacting the stock price.
• Employees may experience uncertainty if the sales are interpreted negatively.

Key Dates

Keywords

CVS Health Corp, Larry Robbins, Glenview Capital, share sale, Form 4, beneficial ownership, stock transaction